{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:32:55Z","timestamp":1786469575371,"version":"build-2736575974"},"reference-count":11,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interv Cardiol"],"abstract":"<jats:p>Aims: Drug-coated balloons (DCBs) are increasingly used in percutaneous coronary intervention (PCI) but there are limited data available on practice patterns. Our survey evaluated the views of interventional cardiologists with respect to various clinical and technical aspects of DCB angioplasty. Methods: A voluntary, online survey involving 13 questions \u2013 the Drug Eluting Technologies Evaluation &amp; Current Trends (DETECT) Clinical Practice Survey \u2013 was conducted in two waves: a census of Irish interventional cardiologists in April 2025 and an onsite survey at the EuroPCR Congress in May 2025. The question topics included indications for DCB use, device selection factors, dual antiplatelet therapy (DAPT) duration and intravascular imaging use. Respondent characteristics were recorded. Results: A total of 136 respondents (126 consultants, 10 fellows) from 39 countries (60 Ireland, 76 EuroPCR) participated in the survey. The survey revealed that most consider a DCB for in-stent restenosis (ISR; 99%), small vessel disease (95%) and bifurcation lesions (77%). A lower proportion consider a DCB strategy in chronic total occlusion (29%), any vessel size (21%) or acute coronary syndrome (17%). No differences by level of interventional experience (&gt;10 years, &lt;10 years or fellow) (\u03c7\u00b2=10.35; p=0.11). DCB comprised 1\u201310% of annual PCI for half of the respondents (55%); most respondents (82%) anticipated an increase in their use. Paclitaxel DCBs were widely available (93%) but sirolimus DCBs less so (55%). DAPT duration post-DCB in chronic coronary syndromes was commonly prescribed for 3 months (43%) or 6 months (33%). Most use intravascular imaging for 21\u201350% of their DCB cases. Conclusion: This survey suggests that DCBs have been widely adopted by interventional cardiologists for the treatment of ISR and small vessel disease, with anticipated growth in the next 2 years.<\/jats:p>","DOI":"10.15420\/icr.2026.03","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:39:40Z","timestamp":1785944380000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation &amp; Current Trends (DETECT) Survey"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-9990","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Callaghan","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-3279","authenticated-orcid":false,"given":"JJ","family":"Coughlan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-1934","authenticated-orcid":false,"given":"Himanshu","family":"Rai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1493-6454","authenticated-orcid":false,"given":"Niall","family":"Connolly","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9083-1374","authenticated-orcid":false,"given":"Muhammad Ali","family":"Jawed","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-2131","authenticated-orcid":false,"given":"Rory","family":"Durand","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Spence","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-9502","authenticated-orcid":false,"given":"R\u00f3is\u00edn","family":"Colleran","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm G","family":"Hanratty","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5224-6393","authenticated-orcid":false,"given":"Robert A","family":"Byrne","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01hxy9878","id-type":"ROR","asserted-by":"publisher"}],"name":"Royal College of Surgeons in Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Fezzi S, Serruys PW, Cortese B, et al. Indications for use of drug-coated balloons in coronary intervention: Academic Research Consortium position statement. J Am Coll Cardiol 2025;86:1170\u2013202. https:\/\/doi.org\/10.1016\/j.jacc.2025.07.049; PMID: 41062231. DOI: 10.1016\/j.jacc.2025.07.049","DOI":"10.1016\/j.jacc.2025.07.049"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Her A-Y, Ahmad WAW, Bang LH, et al. Drug-coated balloons-based intervention for coronary artery disease: the second report of Asia-Pacific Consensus Group. JACC Asia 2025;5:701\u201317. https:\/\/doi.org\/10.1016\/j.jacasi.2025.02.017; PMID: 40304645. DOI: 10.1016\/j.jacasi.2025.02.017","DOI":"10.1016\/j.jacasi.2025.02.017"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Muramatsu T, Kozuma K, Tanabe K, et al. Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 2023;38:166\u201376. https:\/\/doi.org\/10.1007\/s12928-023-00921-2; PMID: 36847902. DOI: 10.1007\/s12928-023-00921-2","DOI":"10.1007\/s12928-023-00921-2"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group. JACC Cardiovasc Interv 2020;13:1391\u2013402. https:\/\/doi.org\/10.1016\/j.jcin.2020.02.043; PMID: 32473887 DOI: 10.1016\/j.jcin.2020.02.043","DOI":"10.1016\/j.jcin.2020.02.043"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Klein LW, Nathan S, Maehara A, et al. SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis. J Soc Cardiovasc Angiogr Interv 2023;2:100971. https:\/\/doi.org\/10.1016\/j.jscai.2023.100971; PMID: 39131655. DOI: 10.1016\/j.jscai.2023.100971","DOI":"10.1016\/j.jscai.2023.100971"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan D, Coughlan JJ, Durand R, et al. Drug-coated balloons in chronic total occlusion percutaneous coronary intervention. Interv Cardiol Clin 2026;15:97\u2013109. https:\/\/doi.org\/10.1016\/j.iccl.2025.09.008; PMID: 41276401. DOI: 10.1016\/j.iccl.2025.09.008","DOI":"10.1016\/j.iccl.2025.09.008"},{"key":"ref6","unstructured":"Byrne RA, Rossello X, Coughlan J, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191; PMID: 37622654."},{"key":"ref7","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J 2024;45:3415\u2013537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177; PMID: 39210710."},{"key":"ref8","unstructured":"Yeh RW, Shlofmitz R, Moses J, et al. Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial. JAMA 2024;331:1015\u201324. https:\/\/doi.org\/10.1001\/jama.2024.1361; PMID: 38460161."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Fezzi S, Giacoppo D, Fahrni G, et al. Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study. Eur Heart J 2025;46:1586\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf002; PMID: 39981922. DOI: 10.1093\/eurheartj\/ehaf002","DOI":"10.1093\/eurheartj\/ehaf002"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan D, Rai H, Giacoppo D, et al. Drug coated balloons versus drug-eluting stents in patients with de novo coronary artery disease. Catheter Cardiovasc Interv 2025;106:1843\u201353. https:\/\/doi.org\/10.1002\/ccd.70005; PMID: 40662340. DOI: 10.1002\/ccd.70005","DOI":"10.1002\/ccd.70005"}],"container-title":["Interventional Cardiology Reviews Research Resources"],"original-title":[],"link":[{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2026.03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:37:27Z","timestamp":1786466247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2026.03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":11,"URL":"https:\/\/doi.org\/10.15420\/icr.2026.03","relation":{},"ISSN":["1756-1477","1756-1485"],"issn-type":[{"value":"1756-1477","type":"print"},{"value":"1756-1485","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"e18"}}